Autoimmunity BioSolutions develops next-generation immuno-corrective therapies targeting genetically-defined subpopulations of patients with autoimmune diseases.

Axonis Therapeutics is a biotechnology company developing novel neuromedicines targeting neurological disorders like epilepsy and pain.

HDAX Therapeutics is developing next-generation HDAC6 inhibitors to treat neurological and cardiometabolic diseases.